Oxford BioDynamics Price Performance
Shares of OBD opened at GBX 14.24 ($0.18) on Tuesday. The company has a current ratio of 2.98, a quick ratio of 2.80 and a debt-to-equity ratio of 99.34. Oxford BioDynamics has a 1 year low of GBX 10.98 ($0.14) and a 1 year high of GBX 33 ($0.41). The stock has a market cap of £20.89 million and a P/E ratio of -1.90. The stock’s 50-day moving average price is GBX 18.11 and its two-hundred day moving average price is GBX 16.09.
Insiders Place Their Bets
In other Oxford BioDynamics news, insider Stephen Charles Diggle acquired 50,000 shares of the business’s stock in a transaction dated Friday, November 11th. The shares were acquired at an average price of GBX 18 ($0.22) per share, for a total transaction of £9,000 ($11,142.75).
Oxford BioDynamics Company Profile
Oxford BioDynamics Plc, a biotechnology company, discovers and develops biomarkers for use in the pharmaceutical and biotechnology industry primarily in the United States and internationally. The company provides EpiSwitch, a proprietary technology platform for the discovery, evaluation, validation, and monitoring of epigenetic biomarkers known as chromosome conformation signatures for use in medical testing kits, disease prediction, diagnosis, and treatment.
- When Will Crane Holdings Take Flight?
- Is It Time To Get Aggressive With Defense Stocks?
- 3 Retail Stocks Ringing the Register in 2023
- EVgo Stock is Charged Up to Ride the EV Adoption Wave
- Qualcomm Gets a Boost from Analysts, but is it Time to Buy?
Receive News & Ratings for Oxford BioDynamics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxford BioDynamics and related companies with MarketBeat.com's FREE daily email newsletter.